Demand for controlled release formulations is expanding considering the tendency of achieving a higher comfort linked to the use of a wide variety of APIs. Controlled released excipients enables the reduction of dosing frequencies, which are particularly beneficial for pediatric and geriatric patients, but are also valued by most patients and in general lead to increases the drugs bioavailability and reduces side effects

How can Clariant help you to get a solution? We offer a wide range of excipients that supports the dissolution rate modification of APIs

• PEGs
• PEG-Derivatives

Reformulation of marketed drugs in controlled-release formats is one of the most common methods for extending the product lifecycle.